1887

Abstract

Japanese encephalitis (JE) remains the leading cause of viral encephalitis in the Asia-Pacific region, and the live vaccine SA14-14-2 is currently recommended by WHO and widely used in Asian countries with a good safety and efficacy profile. In this study, we demonstrated that SA14-14-2 failed to produce NS1’, the larger NS1-related protein, compared with its parental strain SA14 in various cells. Sequence analysis and secondary structure prediction identified a single silent mutation G66A in the NS2A-coding region of SA14-14-2 destabilized the conserved pseudoknot structure, which was associated with a −1 ribosomal frame shift event. Using reverse genetic technology and animal study, we provided solid evidence that this single silent mutation G66A in the NS2A gene abolished the production of NS1’ and reduced neurovirulence and neuroinvasiveness in mice. These findings provide critical information in understanding the molecular mechanism of JE vaccine attenuation and is critical for JE vaccine quality control.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.043844-0
2012-09-01
2019-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/9/1959.html?itemId=/content/journal/jgv/10.1099/vir.0.043844-0&mimeType=html&fmt=ahah

References

  1. Arroyo J. , Guirakhoo F. , Fenner S. , Zhang Z. X. , Monath T. P. , Chambers T. J. . ( 2001; ). Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). . J Virol 75:, 934–942. [CrossRef] [PubMed]
    [Google Scholar]
  2. Avirutnan P. , Zhang L. , Punyadee N. , Manuyakorn A. , Puttikhunt C. , Kasinrerk W. , Malasit P. , Atkinson J. P. , Diamond M. S. . ( 2007; ). Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. . PLoS Pathog 3:, e183. [CrossRef] [PubMed]
    [Google Scholar]
  3. Avirutnan P. , Fuchs A. , Hauhart R. E. , Somnuke P. , Youn S. , Diamond M. S. , Atkinson J. P. . ( 2010; ). Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. . J Exp Med 207:, 793–806. [CrossRef] [PubMed]
    [Google Scholar]
  4. Bista M. B. , Banerjee M. K. , Shin S. H. , Tandan J. B. , Kim M. H. , Sohn Y. M. , Ohrr H. C. , Tang J. L. , Halstead S. B. . ( 2001; ). Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. . Lancet 358:, 791–795. [CrossRef] [PubMed]
    [Google Scholar]
  5. Blitvich B. J. , Scanlon D. , Shiell B. J. , Mackenzie J. S. , Hall R. A. . ( 1999; ). Identification and analysis of truncated and elongated species of the flavivirus NS1 protein. . Virus Res 60:, 67–79. [CrossRef] [PubMed]
    [Google Scholar]
  6. Brierley I. , Pennell S. . ( 2001; ). Structure and function of the stimulatory RNAs involved in programmed eukaryotic-1 ribosomal frameshifting. . Cold Spring Harb Symp Quant Biol 66:, 233–248. [CrossRef] [PubMed]
    [Google Scholar]
  7. Chambers T. J. , Droll D. A. , Jiang X. , Wold W. S. , Nickells J. A. . ( 2007; ). JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease. . Virology 366:, 51–61. [CrossRef] [PubMed]
    [Google Scholar]
  8. Chen L. K. , Liao C. L. , Lin C. G. , Lai S. C. , Liu C. I. , Ma S. H. , Huang Y. Y. , Lin Y. L. . ( 1996; ). Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. . Virology 217:, 220–229. [CrossRef] [PubMed]
    [Google Scholar]
  9. Chung K. M. , Nybakken G. E. , Thompson B. S. , Engle M. J. , Marri A. , Fremont D. H. , Diamond M. S. . ( 2006; ). Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. . J Virol 80:, 1340–1351. [CrossRef] [PubMed]
    [Google Scholar]
  10. Chung K. M. , Thompson B. S. , Fremont D. H. , Diamond M. S. . ( 2007; ). Antibody recognition of cell surface-associated NS1 triggers Fc-γ receptor-mediated phagocytosis and clearance of West Nile virus-infected cells. . J Virol 81:, 9551–9555. [CrossRef] [PubMed]
    [Google Scholar]
  11. Deng Y. Q. , Dai J. X. , Ji G. H. , Jiang T. , Wang H. J. , Yang H. O. , Tan W. L. , Liu R. , Yu M. . & other authors ( 2011; ). A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. . PLoS ONE 6:, e16059. [CrossRef] [PubMed]
    [Google Scholar]
  12. Erlanger T. E. , Weiss S. , Keiser J. , Utzinger J. , Wiedenmayer K. . ( 2009; ). Past, present, and future of Japanese encephalitis. . Emerg Infect Dis 15:, 1–7. [CrossRef] [PubMed]
    [Google Scholar]
  13. Firth A. E. , Atkins J. F. . ( 2009; ). A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flaviviruses suggests NS1′ may derive from ribosomal frameshifting. . Virol J 6:, 14. [CrossRef] [PubMed]
    [Google Scholar]
  14. Firth A. E. , Blitvich B. J. , Wills N. M. , Miller C. L. , Atkins J. F. . ( 2010; ). Evidence for ribosomal frameshifting and a novel overlapping gene in the genomes of insect-specific flaviviruses. . Virology 399:, 153–166. [CrossRef] [PubMed]
    [Google Scholar]
  15. Gatchalian S. , Yao Y. , Zhou B. , Zhang L. , Yoksan S. , Kelly K. , Neuzil K. M. , Yaïch M. , Jacobson J. . ( 2008; ). Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. . Vaccine 26:, 2234–2241. [CrossRef] [PubMed]
    [Google Scholar]
  16. Halstead S. B. , Thomas S. J. . ( 2010; ). Japanese encephalitis: new options for active immunization. . Clin Infect Dis 50:, 1155–1164. [CrossRef] [PubMed]
    [Google Scholar]
  17. Halstead S. B. , Thomas S. J. . ( 2011; ). New Japanese encephalitis vaccines: alternatives to production in mouse brain. . Expert Rev Vaccines 10:, 355–364. [CrossRef] [PubMed]
    [Google Scholar]
  18. Hennessy S. , Liu Z. , Tsai T. F. , Strom B. L. , Wan C. M. , Liu H. L. , Wu T. X. , Yu H. J. , Liu Q. M. . & other authors ( 1996; ). Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. . Lancet 347:, 1583–1586. [CrossRef] [PubMed]
    [Google Scholar]
  19. Khromykh A. A. , Sedlak P. L. , Guyatt K. J. , Hall R. A. , Westaway E. G. . ( 1999; ). Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. . J Virol 73:, 10272–10280.[PubMed]
    [Google Scholar]
  20. Kumar R. , Tripathi P. , Rizvi A. . ( 2009; ). Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. . N Engl J Med 360:, 1465–1466. [CrossRef] [PubMed]
    [Google Scholar]
  21. Li X. F. , Jiang T. , Yu X. D. , Deng Y. Q. , Zhao H. , Zhu Q. Y. , Qin E. D. , Qin C. F. . ( 2010; ). RNA elements within the 5′ untranslated region of the West Nile virus genome are critical for RNA synthesis and virus replication. . J Gen Virol 91:, 1218–1223. [CrossRef] [PubMed]
    [Google Scholar]
  22. Li M. H. , Fu S. H. , Chen W. X. , Wang H. Y. , Guo Y. H. , Liu Q. Y. , Li Y. X. , Luo H. M. , Da W. . & other authors ( 2011; ). Genotype V Japanese encephalitis virus is emerging. . PLoS Negl Trop Dis 5:, e1231. [CrossRef] [PubMed]
    [Google Scholar]
  23. Lin Y. L. , Chen L. K. , Liao C. L. , Yeh C. T. , Ma S. H. , Chen J. L. , Huang Y. L. , Chen S. S. , Chiang H. Y. . ( 1998; ). DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. . J Virol 72:, 191–200.[PubMed]
    [Google Scholar]
  24. Lindenbach B. D. , Rice C. M. . ( 1997; ). trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. . J Virol 71:, 9608–9617.[PubMed]
    [Google Scholar]
  25. Loughran G. , Firth A. E. , Atkins J. F. . ( 2011; ). Ribosomal frameshifting into an overlapping gene in the 2B-encoding region of the cardiovirus genome. . Proc Natl Acad Sci U S A 108:, E1111–E1119. [CrossRef] [PubMed]
    [Google Scholar]
  26. Mackenzie J. S. , Gubler D. J. , Petersen L. R. . ( 2004; ). Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. . Nat Med 10: (Suppl.), S98–S109. [CrossRef] [PubMed]
    [Google Scholar]
  27. Mason P. W. . ( 1989; ). Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. . Virology 169:, 354–364. [CrossRef] [PubMed]
    [Google Scholar]
  28. Melian E. B. , Hinzman E. , Nagasaki T. , Firth A. E. , Wills N. M. , Nouwens A. S. , Blitvich B. J. , Leung J. , Funk A. . & other authors ( 2010; ). NS1′ of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. . J Virol 84:, 1641–1647. [CrossRef] [PubMed]
    [Google Scholar]
  29. Ni H. , Burns N. J. , Chang G. J. , Zhang M. J. , Wills M. R. , Trent D. W. , Sanders P. G. , Barrett A. D. . ( 1994; ). Comparison of nucleotide and deduced amino acid sequence of the 5′ non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. . J Gen Virol 75:, 1505–1510. [CrossRef] [PubMed]
    [Google Scholar]
  30. Ni H. , Chang G. J. , Xie H. , Trent D. W. , Barrett A. D. . ( 1995; ). Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. . J Gen Virol 76:, 409–413. [CrossRef] [PubMed]
    [Google Scholar]
  31. Nitayaphan S. , Grant J. A. , Chang G. J. , Trent D. W. . ( 1990; ). Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. . Virology 177:, 541–552. [CrossRef] [PubMed]
    [Google Scholar]
  32. Pan X. L. , Liu H. , Wang H. Y. , Fu S. H. , Liu H. Z. , Zhang H. L. , Li M. H. , Gao X. Y. , Wang J. L. . & other authors ( 2011; ). Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. . J Virol 85:, 9847–9853. [CrossRef] [PubMed]
    [Google Scholar]
  33. Reeder J. , Steffen P. , Giegerich R. . ( 2007; ). pknotsRG: RNA pseudoknot folding including near-optimal structures and sliding windows. . Nucleic Acids Res 35: (Web Server issue), W320–W324. [CrossRef] [PubMed]
    [Google Scholar]
  34. Solomon T. . ( 2003; ). Recent advances in Japanese encephalitis. . J Neurovirol 9:, 274–283.[PubMed] [CrossRef]
    [Google Scholar]
  35. Solomon T. . ( 2004; ). Flavivirus encephalitis. . N Engl J Med 351:, 370–378. [CrossRef] [PubMed]
    [Google Scholar]
  36. Sun J. , Yu Y. , Deubel V. . ( 2012; ). Japanese encephalitis virus NS1′ protein depends on pseudoknot secondary structure and is cleaved by caspase during virus infection and cell apoptosis. . Microbes Infect. [CrossRef] [PubMed]
    [Google Scholar]
  37. Tandan J. B. , Ohrr H. , Sohn Y. M. , Yoksan S. , Ji M. , Nam C. M. , Halstead S. B. . ( 2007; ). Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. . Vaccine 25:, 5041–5045. [CrossRef] [PubMed]
    [Google Scholar]
  38. van den Hurk A. F. , Ritchie S. A. , Mackenzie J. S. . ( 2009; ). Ecology and geographical expansion of Japanese encephalitis virus. . Annu Rev Entomol 54:, 17–35. [CrossRef] [PubMed]
    [Google Scholar]
  39. Wang B. , Hua R. H. , Tian Z. J. , Chen N. S. , Zhao F. R. , Liu T. Q. , Wang Y. F. , Tong G. Z. . ( 2009; ). Identification of a virus-specific and conserved B-cell epitope on NS1 protein of Japanese encephalitis virus. . Virus Res 141:, 90–95. [CrossRef] [PubMed]
    [Google Scholar]
  40. Winkelmann E. R. , Widman D. G. , Suzuki R. , Mason P. W. . ( 2011; ). Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1. . Virology 421:, 96–104. [CrossRef] [PubMed]
    [Google Scholar]
  41. World Health Organization . ( 2005; ). Global Advisory Committee on vaccine safety, 9–10 June 2005. . Wkly Epidemiol Rec 80:, 242–243. [CrossRef] [PubMed]
    [Google Scholar]
  42. Youn S. , Cho H. , Fremont D. H. , Diamond M. S. . ( 2010; ). A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition. . J Virol 84:, 9516–9532. [CrossRef] [PubMed]
    [Google Scholar]
  43. Yu Y. . ( 2010; ). Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. . Vaccine 28:, 3635–3641. [CrossRef] [PubMed]
    [Google Scholar]
  44. Zhao Z. , Date T. , Li Y. , Kato T. , Miyamoto M. , Yasui K. , Wakita T. . ( 2005; ). Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. . J Gen Virol 86:, 2209–2220. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.043844-0
Loading
/content/journal/jgv/10.1099/vir.0.043844-0
Loading

Data & Media loading...

Supplements

Supplementary material 

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error